Epilepsy

• FDA label_change · 2009-04-23
  FDA Approved: ZONEGRAN — Supplemental Application (Advanz Pharma (US) Corp.)

  The FDA lists a supplemental application for Zonegran (zonisamide) submitted by Advanz Pharma (US) Corp.

• FDA label_change · 2009-03-25
  FDA Approved: LAMOTRIGINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

  The FDA approved a supplemental application for lamotrigine from Sun Pharmaceutical Industries, Inc.

• FDA label_change · 2007-12-11
  FDA Approved: TEGRETOL — Supplemental Application (Novartis Pharmaceuticals Corporation)

  The FDA approved a supplemental application for Tegretol (carbamazepine) filed by Novartis Pharmaceuticals Corporation. The update concerns …

• FDA label_change · 2007-01-09
  FDA Approved: TRILEPTAL — Supplemental Application (Novartis Pharmaceuticals Corporation)

  FDA approved a supplemental application for TRILEPTAL (oxcarbazepine) filed by Novartis Pharmaceuticals Corporation, likely involving a labe…

• FDA label_change · 2006-12-07
  FDA Approved: GABAPENTIN — Supplemental Application (Granules Pharmaceuticals Inc)

  FDA approved a supplemental application for gabapentin—specifically a granule formulation—from Granules Pharmaceuticals Inc.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA label_change · 2006-10-13
  FDA Approved: DEPAKOTE — Supplemental Application (AbbVie Inc.)

  The FDA approved a supplemental application for Depakote (divalproex sodium) submitted by AbbVie Inc. This action relates to changes impleme…